Trial intelligence / Profile preview

Different Doses of Remimazolam for General Anesthesia in Elderly Hip Replacement

ChiCTR2500097831Phase 4Not yet recruiting

Sponsor
Hefei BOE Hospital
Start
Feb 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam in Neck Of Femur Fracture and osteonecrosis of the hip (2 arms), sponsored by Hefei BOE Hospital. Primary endpoint: Tracheal catheter removal time. Planned start Feb 2025; status: not yet recruiting.

02

Drugs

remimazolam
03

Conditions

Neck Of Femur Fractureosteonecrosis of the hip

Beyond the preview

Go deeper on ChiCTR2500097831.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500097831.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call